Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) PT at $16.25

Pediatrix Medical Group, Inc. (NYSE:MD) has received a consensus rating of “Hold” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $17.08.

A number of equities research analysts recently issued reports on the stock. Truist Financial upped their price target on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Friday, February 21st. Jefferies Financial Group increased their price target on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. UBS Group raised their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research report on Monday, November 4th.

Institutional Investors Weigh In On Pediatrix Medical Group

Several hedge funds and other institutional investors have recently modified their holdings of MD. State Street Corp increased its stake in Pediatrix Medical Group by 1.4% in the third quarter. State Street Corp now owns 3,540,791 shares of the company’s stock worth $41,038,000 after purchasing an additional 50,597 shares during the period. Nordea Investment Management AB lifted its holdings in Pediatrix Medical Group by 51.6% during the 4th quarter. Nordea Investment Management AB now owns 263,633 shares of the company’s stock valued at $3,504,000 after buying an additional 89,739 shares in the last quarter. Barclays PLC lifted its holdings in Pediatrix Medical Group by 302.9% during the 3rd quarter. Barclays PLC now owns 142,087 shares of the company’s stock valued at $1,646,000 after buying an additional 106,817 shares in the last quarter. Franklin Resources Inc. bought a new position in Pediatrix Medical Group in the 3rd quarter worth about $598,000. Finally, Principal Financial Group Inc. increased its position in shares of Pediatrix Medical Group by 14.1% during the third quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock worth $5,953,000 after acquiring an additional 63,581 shares during the period. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Down 1.9 %

MD opened at $15.38 on Wednesday. The company has a market capitalization of $1.32 billion, a PE ratio of -12.81, a price-to-earnings-growth ratio of 1.74 and a beta of 1.57. The firm has a 50-day simple moving average of $13.94 and a two-hundred day simple moving average of $13.09. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $17.67.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Analysts forecast that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.